![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-3989|11|1|94-95
ISSN: 1871-5265
Source: Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.11, Iss.1, 2011-02, pp. : 94-95
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Albendazole/mebendazole: Drug hypersensitivity: case report
Reactions Weekly, Vol. 1, Iss. 1155, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Vaccines Against Drugs of Abuse: A Viable Treatment Option?
By Kantak K.M.
Drugs, Vol. 63, Iss. 4, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Is tocilizumab an option for the treatment of arthritis?
Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 11, 2008-08 ,pp. :